Full name
"CONTACT PHARM" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"CONTACT PHARM" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ŻELIGOWSKIEGO 8/10, 90-753 ŁÓDŹ
TAX ID7272769126
Rate company:
"CONTACT PHARM" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7272769126
KRS0000366927
Share capital10,000.00 zł
address
UL. ŻELIGOWSKIEGO 8/10, 90-753 ŁÓDŹ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7272769126
REGON
100968945
KRS
0000366927
Legal form
limited liability company
Register Address
UL. ŻELIGOWSKIEGO 8/10, 90-753 ŁÓDŹ
Date of registration in KRS
2010-09-30
Date of commencement of economic activity
2010-09-30
Act signature
LD.XX NS-REJ.KRS/27553/17/846/ADE
Pkd codes
82.20.Z - Call center activities
46 - Wholesale trade
58 - Publishing activities
62.09.Z - Activities related to programming, IT consulting, and related activities
63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
70.10.Z - Head office activities
73.20.Z - Market research and public opinion polling
77.11.Z - Rental and leasing of passenger cars and light motor vehicles
77.12.Z - Rental and leasing of trucks
82.99.Z - Other business support activities, not elsewhere classified
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | -0,3 | 0,1 | -0 | -180 |
EBITDA | -0,3 | 0,1 | -0 | -180 |
Short time liabilities | 0 | 0 | 0,1 | -∞ |
Equity capital | 0,7 | 0,8 | 0,7 | -5,5 |
Operating profit (EBIT) | -0,3 | 0,1 | -0 | -180 |
Assets | 1,3 | 0,8 | 0,8 | 2,5 |
Net profit (loss) | -0,3 | 0 | -0 | -188,3 |
Cash | 0,7 | 0,2 | 0,1 | -24,2 |
Net income from sale | 0,9 | 0,9 | 1,8 | 100 |
Liabilities and provisions for liabilities | 0,6 | 0 | 0,1 | -∞ |
Working assets | 0,8 | 0,3 | 0,3 | 7,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -45 | 6,3 | -5,9 | -12,2 |
Equity capital to total assets | 54,5 | 100 | 92,2 | -7,8 |
Gross profit margin | -35,9 | 5,9 | -2,4 | -8,3 |
EBITDA Margin | -35,9 | 5,9 | -2,4 | -8,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 12 | 12 |
Current financial liquidity indicator | 1.3632667064666748 | 4.635121822357178 | 3,2 | |
Net dept to EBITDA | 2.3087589740753174 | -2.848302125930786 | 2.697169780731201 | 5,5 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download xmlShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.